Omeprazole Enteric-coated Capsules Passed Generics Consistency Evaluation
Source: | Author:pmo6650cc | Published time: 2020-03-09 | 1868 Views | Share:

On March 9, 2020, Changjiang Health Hailing Pharmaceutical received the Approval Letter of Drug Supplementary Application for Omeprazole Enteric-coated Capsules issued by National Medical Products Administration, indicating that the drug passed the consistency evaluation of quality and efficacy of generic drugs. The whole project lasted for three years and the drug became the first digestive medicine of the company that passed the consistency evaluation.

 

Omeprazole Enteric-coated Capsules are indicated for treatment of gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma). It is the fast-acting drug product with long-lasting effect and very competitive among digestive system medicines. Thanks to the approval of consistency evaluation, the market competitiveness of the company will be further strengthened, which will help expand market sales and will have a positive impact on the company's performance.

NEWS

 Contact Us —

 Address:No.281, Nanhai Avenue, Haikou, Hainan,

 570311, PRC

Tel:+86 898-68639900

 Email:ia@hailingpharm.com